Viveve Medical Inc 's ability to collect accounts receivable sequentially worsen to 10.04, indicating more challenging environment then in the second quarter 2022, but still, it is a far cry from any concerns. Viveve Medical Inc 's Accounts Receivable average collection period in the Sep 30 2022 quarter, has increased to 36 days, from 32 days, in the Jun 30 2022 quarter.

If we take a look into Healthcare sector 342 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2022 from 925 to 2555.

What is Receivable Turnover Ratio?
What is Viveve Medical Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VIVE Receivables Turnover Ratio	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Receivable Change	67.32 %	15.09 %	51.49 %	-28.7 %	-25.4 %
Y / Y Revenue Change	4.21 %	8.52 %	13.17 %	-12.38 %	6.04 %
Receivable Turnover Ratio (TTM)	10.04	11.39	11.67	12.27	11.51
VIVE's Total Ranking	# 2555	# 925	# 1271	# 2520	# 2518
Accounts Receivable average collection period days	36	32	31	30	32
Seq. Receivable Change	7.37 %	57.37 %	-7.29 %	6.81 %	-26.15 %
Seq. Revenue Change	-6.18 %	9.38 %	-3.81 %	5.57 %	-2.3 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 136
Healthcare Sector	# 343
Overall Market	# 2555

Receivable Turnover Ratio Statistics
High	Average	Low
0.44	0.26	0.08
(Dec 31 2016)		(Dec 31 2017)

VIVE Company Profile • Back to VIVE Efficiency Comparisons • Compare VIVE Receivables Turnover Ratio to its Competitors

Financial Statements
Viveve Medical Inc 's Accounts Receivable	$ 1 Millions	Visit VIVE's Balance sheet
Viveve Medical Inc 's Sales TTM	$ 7 Millions	Visit VIVE's Income Statement
Sources of VIVE's Revenues		Visit VIVE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VIVE's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VIVE's Growth Rates	VIVE's Roa	VIVE's Inventory Turnover Ratio	VIVE's Dividend Comparisons
VIVE's Profitability Ratios	VIVE's Roi	VIVE's Asset Turnover Ratio	VIVE's Dividend Growth
VIVE's Valuation Ratios	VIVE's Roe	VIVE's Financial Strength Ratios	VIVE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2022	Receivable at quarter ending Sep 30 2022
Catalyst Pharmaceuticals Inc	21.25	$ 191.755 Millions	$ 9.024 Millions
Talkspace Inc	21.05	$ 145.655 Millions	$ 6.920 Millions
Nutriband Inc	20.57	$ 2.044 Millions	$ 0.099 Millions
Anika Therapeutics Inc	20.43	$ 152.435 Millions	$ 7.461 Millions
Wearable Health Solutions, Inc.	20.27	$ 0.960 Millions	$ 0.047 Millions
U s Stem Cell Inc	20.17	$ 0.086 Millions	$ 0.004 Millions
Biomerica Inc	19.29	$ 19.247 Millions	$ 0.998 Millions
Intellia Therapeutics Inc	19.20	$ 51.402 Millions	$ 2.677 Millions
Lftd Partners Inc	19.07	$ 58.890 Millions	$ 3.087 Millions
Vystar Corporation	18.33	$ 15.105 Millions	$ 0.824 Millions
Arcturus Therapeutics Holdings Inc	18.15	$ 51.500 Millions	$ 2.837 Millions
C4 Therapeutics Inc	18.09	$ 48.320 Millions	$ 2.672 Millions
Statera Biopharma Inc fka Cytocom Inc	18.01	$ 3.688 Millions	$ 0.205 Millions
Sangamo Therapeutics Inc	17.93	$ 112.055 Millions	$ 6.248 Millions
Zomedica Corp	17.70	$ 12.688 Millions	$ 0.717 Millions
Theralink Technologies Inc	17.62	$ 0.568 Millions	$ 0.032 Millions
Ainos Inc	17.57	$ 1.758 Millions	$ 0.100 Millions
Innovage Holding Corp	17.37	$ 696.788 Millions	$ 40.123 Millions
Electrocore Inc	17.28	$ 7.523 Millions	$ 0.435 Millions
Revance Therapeutics Inc	17.28	$ 108.594 Millions	$ 6.285 Millions
Strata Critical Medical Inc	17.26	$ 132.603 Millions	$ 7.682 Millions
Advanced Container Technologies Inc	17.16	$ 3.566 Millions	$ 0.208 Millions
Chemed Corporation	16.69	$ 2,139.657 Millions	$ 128.188 Millions
Ethema Health Corporation	16.39	$ 4.475 Millions	$ 0.273 Millions
Palvella Therapeutics Inc	16.17	$ 28.499 Millions	$ 1.763 Millions
Poseida Therapeutics Inc	15.68	$ 151.679 Millions	$ 9.675 Millions
Qhslab Inc	15.51	$ 1.305 Millions	$ 0.084 Millions
Endonovo Therapeutics Inc	15.04	$ 0.014 Millions	$ 0.001 Millions
Cv Sciences Inc	14.99	$ 17.305 Millions	$ 1.154 Millions
Regenxbio Inc	14.83	$ 480.034 Millions	$ 32.378 Millions

Date modified: 2026-08-29T17:33:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.